Human Papillomavirus and Cervical Cancer: Not Just a Sexually Transmitted Disease
- 1 May 2003
- journal article
- review article
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 7 (3) , 271-276
- https://doi.org/10.1188/03.cjon.271-276
Abstract
The human papillomavirus (HPV) is the cause of virtually all cancers of the cervix, the fourth most common cancer in women in the United States. HPV is sexually transmitted, and the lifetime risk of contracting the virus is estimated to be 75%-90%. New methods of detecting HPV infection and cellular changes (dysplasia) caused by HPV can greatly reduce the mortality associated with this virus. More than 100 types of HPV exist and may be classified as low-, intermediate-, or high-risk in terms of causing cancer. The virus can cause genital warts, subclinical dysplasia, and cancer. Nurses play an important role in educating patients regarding HPV and preventive measures as well as in screening and treatment. Most women diagnosed with HPV need emotional support and factual information provided in a supportive, nonjudgmental manner. Nurses can meet this challenge and make a difference in reducing the incidence and mortality of cervical cancer.Keywords
This publication has 26 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus VaccineEpidemiology, 2002
- Environmental co-factors in HPV carcinogenesisVirus Research, 2002
- Active and passive smoking, high-risk human papillomaviruses and cervical neoplasiaCancer Detection Prevention, 2002
- Human papillomavirus: a reviewDermatologic Clinics, 2002
- Persistent human papillomavirus infection and cervical neoplasiaThe Lancet Oncology, 2002
- Human Papillomavirus and Cervical NeoplasiaCancer Investigation, 2002
- Infection with human papillomavirus: Update on epidemiology, diagnosis, and treatmentCurrent Infectious Disease Reports, 2000
- Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasiaJournal of Medical Microbiology, 1997
- Topical 5-Fluorouracil in the Treatment of Cervical Human Papillomavirus InfectionGynecologic and Obstetric Investigation, 1996